Synageva BioPharma (GEVA) Reports First Quarter 2014 Financial Results
5/1/2014 2:44:54 PM
Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today reported first quarter 2014 financial results, and provided other business updates.
Help employers find you! Check out all the jobs and post your resume.
comments powered by